Innate Pharma SA (IPHA) stock
IPHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as IPHYF
$1.38−0.11 (-7.38%)
Close on Nov 13, 2026Market cap $129.33MP/E –Yield –
Innate Pharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Innate Pharma's market cap was $142.45M on Nov 11, 2026, against $158.05M a year earlier. Over the last 5 years it ranged from $114.68M to $359.94M, with a median of $184.24M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $142.45M | +0.4% |
| 2025 | Dec 31, 2025 | $141.84M | -4.2% |
| 2024 | Dec 31, 2024 | $148.03M | -33.6% |
| 2023 | Dec 29, 2023 | $222.99M | -24.8% |
| 2022 | Dec 30, 2022 | $296.69M | -17.6% |
| 2021 | Dec 31, 2021 | $359.94M | +31.5% |
| 2020 | Dec 31, 2020 | $273.66M | -27.7% |
| 2019 | Dec 31, 2019 | $378.52M | – |
See a number that looks wrong?